Gemayel Jack, Chebly Alain, Kourie Hampig, Hanna Colette, Mheidly Kayane, Mhanna Melissa, Karam Farah, Ghoussaini Daniel, Najjar Paula El, Khalil Charbel
Faculty of Sciences Balamand University Beirut Lebanon.
FMPS Holding BIOTECKNO s.a.l. Research and Quality Solutions Naccash Beirut 60 247 Lebanon.
Adv Genet (Hoboken). 2024 Feb 5;5(1):2300201. doi: 10.1002/ggn2.202300201. eCollection 2024 Mar.
Cancer is one of the foremost causes of mortality. The human genome remains stable over time. However, human activities and environmental factors have the power to influence the prevalence of certain types of mutations. This goes to the excessive progress of xenobiotics and industrial development that is expanding the territory for cancers to develop. The mechanisms involved in immune responses against cancer are widely studied. Genome editing has changed the genome-based immunotherapy process in the human body and has opened a new era for cancer treatment. In this review, recent cancer immunotherapies and the use of genome engineering technology are largely focused on.
癌症是主要的致死原因之一。人类基因组随时间推移保持稳定。然而,人类活动和环境因素有能力影响某些类型突变的发生率。这归因于外源性物质的过度发展和工业发展,它们正在扩大癌症发生的范围。针对癌症的免疫反应所涉及的机制已得到广泛研究。基因组编辑改变了人体基于基因组的免疫治疗过程,并开启了癌症治疗的新纪元。在本综述中,主要聚焦于近期的癌症免疫疗法以及基因组工程技术的应用。